**Meet the editors**

Ana Cristina Andreazza obtained her PhD in Biochemistry from Federal University of Rio Grande do Sul, RS, Brazil in May 2008. Her research interests include the role of biochemical pathways in the pathophysiology of mood disorder, particularly those involving oxidative stress and mitochondrial dysfunction. Specifically, she is interested in exploring the possible connections between

molecular mechanisms that lead to synaptic alterations and those which may be potential avenues for therapy. For example, many proteins are targets for oxidative damage in BD, which include dopamine, synaptophysin, cytochrome C, in addition to mitochondrial proteins. Given the clear evidence from multiple sources of increased oxidative stress in BD, Dr. Andreazza's next step is to identify the protein targets for oxidation in BD. Dr. Andreazza has published several research articles in peer reviewed journals and has presented her work at several national and international scientific conferences. Currently, Dr. Andreazza is an Assistant Professor at Department of Pharmacology at the University of Toronto and is cross-appointed as an Independent Scientist at Centre for Addiction and Mental Health in Toronto, Canada, and an Assistant Professor at Department of Psychiatry at the University of Toronto.

Gustavo Scola is a Postdoctoral Research Fellow at Dr. Andreazza's lab. He is currently working to develop new approaches for the intervention of neuropsychiatric disorders. He obtained his PhD at the Institute of Biotechnology, University of Caxias do Sul, Brazil. His aspirations are to understand the molecular aspects of neuropsychiatric disorders and cancer. Currently, he is

developing biomarkers and potential novel therapeutics, mainly natural compounds for the management of these disorders. Dr. Scola is appointed with the Centre for Addiction and Mental Health, the Department of Psychiatry and Pharmacology at the University of Toronto.
